Another HRS in the books!

• excellent science,
• increasing advocacy
• most importantly, wonderful friendships & connections with #EPeeps & #WomeninEP across the globe

So grateful to have been a part of #HRS2024 ❤️ Next year: San Diego! #HRS2025

Heart Rhythm Society Heart Rhythm TV

What an incredible #HRS2024 !

It was inspiring to connect with the global EP community in #Boston and online. A huge #thankyou to the speakers, sponsors, and attendees who made this event a success! Here's to continuing the important work of improving care for patients with heart

Honor covering the Heart Rhythm Society sessions with you all. See you at HRS2025!
#PaceSetter Ahmed Nagy Edmond Cronin Faisal Merchant JK Han MD Julie Shea, NP Shanta Chakrabarti Sri Sundaram Stefan Simović Sandeep Gautam

That’s a wrap #HRS2024 ! What a weekend in Boston. Can’t wait to see #EPeeps and all new science again next year in San Diego for #HRS2025 ! Stay tuned to Heart Rhythm TV throughout the year for all your relevant EP content! And keep advocating! We are making progress. Heart Rhythm Society

Full paper coming soon. Important and under-appreciated story in ICD space. Thanks to #PaceMate for the remarkable data and my partner with this work Benjamin Steinberg

Heart Rhythm Society Jodie Hurwitz Thank you Jodie Hurwitz and congratulations to Kenneth Ellenbogen !! We #EPeeps are so lucky to have both of you as role models and teachers.

We still haven’t hit the ceiling for RF ablation, as demonstrated by Paul Zei and colleagues with the ongoing REAL-AF registry! Click the link for full video #EPeeps #HRS2024 Brigham EP

Hyde park was a great addition to #HRS20204 . The lack of slides was daunting but made the sessions much more conversational and interactive. I really enjoyed these over the past few days

Heart Rhythm Society

Thank you #HRS2024 for an amazing science, network and knowledge!

See you all at the #HRS2025 in San Diego in April 24-27, 2025

#PaceSetter Heart Rhythm Society

Efficacy and Safety of Apixaban according to the CHADS2-VASc score in AHREs - ARTESiA subanalysis by Jeffrey Healey

Absolute risk reduction for stroke and systemic embolism only in pts with CHADS2-VASc >4

Manuscript 👉 jacc.org/doi/10.1016/j.…

#HRS2024 Heart Rhythm Society

After a year of dedicated service and outstanding leadership, Jodie Hurwitz has ended her role as HRS President. HRS extends its deepest gratitude to Dr. Hurwitz for her invaluable contributions and commitment to the success of HRS throughout her tenure.

The Society is pleased to

As #HRS2024 Biston draws to a close, big shout out to Mina Chung Mina Chung MD , Sana Al-Khatib & all Heart Rhythm Society colleagues and staff for a superbly organized, exciting and thoughtful annual sessions! You have set a high bar for #HRS2025 San Diego! JK Han MD Kamala Tamirisa MD

My mentor, EP father-figure, dear friend and colleague was sworn in as the Heart Rhythm Society President yesterday evening. There is no one more deservant of the honor or will try harder to do his best in that role than Kenneth Ellenbogen. HRS and #epeeps are lucky to have you.
#HRS2024

#HRS2024 #JACC LBCT SimPub: In this current subgroup analysis from the #ARTESiA trial, Dr. Renato D Lopes, et al showed that CHA2DS2-VASc score helps in guiding oral anticoagulation for patients with subclinical #AFib . bit.ly/4bI3IXj

#cvCoag DrMGold Boriani Giuseppe

Really important analysis from the ARTESiA trial to help physicians to find patients with subclinical AF who might benefit the most from OAC. Results just presented at the LBCT session at HRS. William F McIntyre Jeff Healey PHRI.ca Population Health Research Institute 🇨🇦 Duke Clinical Research Institute

From The ARTESiA Trial 🇨🇦 at #HRS2024 and in JACC Journals:

Device-detected subclinical + CHA2DS2-VASc score >4: stroke risk 2.2%/yr. Clear benefit to OAC with apixaban

No benefit with CHA2DS2-VASc score <4.

Grey zone at CHA2DS2-VASc =4. PHRI.ca Population Health Research Institute 🇨🇦 Duke Clinical Research Institute

Excited about our work quantifying battery longevity in ICDs over time, by type and by vendor. Important insights, including that adding an atrial lead costs 2-3 years of battery longevity. Plus, nothing is cooler than presenting while wearing an 80’s style Walkman AV device.

LA flutter doubles with more ablation from PVI to PVI+PWI to PVI + linear/CFAE in 4783 patients undergoing AF ablation FUp 6 yrs ⬆️abl⬆️gaps⬆️reentry ⁦JACC Journals⁩

Outcomes with and without OAC in patients with prior stroke with device-detected AF - the NOAH-AFNET-6 trial by Paulus Kirchhof

- No effect of OAC on stroke, SE or CV death in patients with AHREs and prior stroke.
- No detectable treatment interaction between prior stroke/TIA

No difference in outcomes according to treatment group and prior stroke/no prior stroke status
Also no difference in stroke severity
Signal for more bleeding
#HRS2024